Uganda Gets Novel Antibodies, Antivirals From US For Ebola
Remdesivir from Gilead Sciences and MBP134, an experimental Ebola antibody drug from Mapp Biopharmaceutical Inc., were sent by the United States last week, ending...
Competition From Biosimilars Saves $21bn For US Healthcare
Amgen's market forecast for 2022 explains how competition has led to healthcare cost savings and predicts that a sizable proportion of biologics will compete...
FDA Explores For Ways That Help Tailored Gene Treatment
Peter Marks, a top official at the Food and Drug Administration, is not tasked with determining if the expense of the medicines his teams...
Merck And Moderna Sign $250mn Partnership For Cancer Vaccine
On October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the US and Canada, had chosen to use its $250...
Pharma Production Sustainability Focussed Due To Inflation
Late in September, the trade group Medicines for Europe wrote an open letter to the European Commission (EC) requesting that the pharmaceutical sector be...
FDA Okays Pfizer, Moderna Omicron Boosters For Kids
Following a decision by the Food and Drug Administration to broaden its authorization of reformulated shots from Moderna and partners Pfizer and BioNTech, kids...
Pistoia Alliance To Study Clinical Trial Ecology Effect
The Clinical Trials Environmental Impact Community of Interest (CoI) has been launched by The Pistoia Alliance, a global, non-profit alliance that promotes increased collaboration...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...